BCM
AGRX

Bridgeway Capital Management’s Agile Therapeutics AGRX Stock Holding History

Bridgeway Capital Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-61
Closed -$60K – 1487
2018
Q2 		$60K Sell
61
-36
-37% -$126K ﹤0.01% 1389
2018
Q1 		$499K Buy
97
+35
+56% +$231K 0.01% 1096
2017
Q4 		$335K Hold
62
– – ﹤0.01% 1188
2017
Q3 		$549K Buy
62
+1
+2% +$7.68K 0.01% 1068
2017
Q2 		$458K Sell
61
-38
-38% -$263K 0.01% 1115
2017
Q1 		$631K Buy
99
+41
+71% +$206K 0.01% 980
2016
Q4 		$663K Sell
58
-25
-30% -$350K 0.01% 967
2016
Q3 		$1.15M Buy
83
+27
+48% +$385K 0.02% 739
2016
Q2 		$855K Buy
56
+22
+65% +$301K 0.01% 841
2016
Q1 		$418K Hold
34
– – 0.01% 1116
2015
Q4 		$657K Hold
34
– – 0.01% 948
2015
Q3 		$454K Buy
34
+10
+42% +$178K 0.01% 1081
2015
Q2 		$421K Buy
24
+19
+380% +$405K 0.01% 1148
2015
Q1 		$95K Buy
+5
New +$87.6K ﹤0.01% 1417

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return